Advances of homeobox gene MEOX1 in tumors

doi:10.3760/cma.j.issn.1673-422X.2019.05.005

Abstract

Abstract: As a homeobox transcription factor, MEOX1 can regulate the target genes by binding the specific DNA sequence. MEOX1 not only plays essential roles in cell proliferation, migration and differentiation, but also participates in the formation of skeleton, muscle and blood vessel during embryonic development. Recent studies demonstrate that MEOX1 is over-expressed in breast cancer, lung cancer, ovarian cancer and prostate cancer tissues, which is closely associated with lymph node metastasis and poor prognosis in patients with cancer. Furthermore, MEOX1 can regulate the proliferation and migration of cancer cells, which suggests that it plays an important role in the occurrence and development of tumors.

Key words: Genes, homeobox, Neoplasms, MEOX1

Zhang Yuan, Sun Lichao. Advances of homeobox gene MEOX1 in tumors[J]. Journal of International Oncology, 2019, 46(5): 278-280.

References

［1］ Monterisi S, Lo Riso P, Russo K, et al. HOXB7 overexpression in lung cancer is a hallmark of acquired stemlike phenotype［J］. Oncogene, 2018, 37(26): 3575-3588. DOI: 10.1038/s41388-018-0229-9. ［2］ Hu H, Chen Y, Cheng S, et al. Dysregulated expression of homebox gene HOXA13 is correlated with the poor prognosis in bladder cancer［J］. Wien Klin Wochenschr, 2017, 129(11-12): 391397. DOI: 10.1007/s0050801611084. ［3］ Skvarova Kramarzova K, Fiser K, Mejstrikova E, et al. Homeobox gene expression in acute myeloid leukemia is linked to typical underlying molecular aberrations［J］. J Hematol Oncol, 2014, 7: 94. DOI: 10.1186/s1304501400940. ［4］ Futreal PA, Cochran C, Rosenthal J, et al. Isolation of a diverged homeobox gene, MOX1, from the BRCA1 region on 17q21 by solution hybrid capture［J］. Hum Mol Genet, 1994, 3(8): 1359-1364. ［5］ Sawamiphak S, Stainier DY. Developmental biology: it takes muscle to make blood cells［J］. Nature, 2014, 512(7514): 257-258. DOI: 10.1038/nature13740. ［6］ Karaca E, Yuregir OO, Bozdogan ST, et al. Rare variants in the notch signaling pathway describe a novel type of autosomal recessive KlippelFeil syndrome［J］. Am J Med Genet A, 2015, 167A(11): 2795-2799. DOI: 10.1002/ajmg.a.37263. ［7］ Wu B, Zhang L, Zhu YH, et al. Mesoderm/mesenchyme homeobox gene 1 promotes vascular smooth muscle cell phenotypic modulation and vascular remodeling［J］. Int J Cardiol, 2018, 251: 82-89. DOI: 10.1016/j.ijcard.2017.10.098. ［8］ Nguyen PD, Gurevich DB, Sonntag C, et al. Muscle stem cells undergo extensive clonal drift during tissue growth via Meox1mediated induction of G2 cellcycle arrest［J］. Cell Stem Cell, 2017, 21(1): 107-119, e6. DOI: 10.1016/j.stem.2017.06.003. ［9］ Lefebvre M, DieuxCoeslier A, Baujat G, et al. Diagnostic strategy in segmentation defect of the vertebrae: a retrospective study of 73 patients［J］. J Med Genet, 2018, 55(6): 422-429. DOI: 10.1136/jmedgenet-2017-104939. ［10］ Dauer MVP, Currie PD, Berger J. Skeletal malformations of Meox1deficient zebrafish resemble human KlippelFeil syndrome［J］. J Anat, 2018, 233(6): 687-695. DOI: 10.1111/joa.12890. ［11］ Thiaville MM, Stoeck A, Chen L, et al. Identification of PBX1 target genes in cancer cells by global mapping of PBX1 binding sites［J］. PLoS One, 2012, 7(5): e36054. DOI: 10.1371/journal.pone.0036054. ［12］ Chen X, Jung JG, ShajahanHaq AN, et al. ChIPBIT: bayesian inference of target genes using a novel joint probabilistic model of ChIPseq profiles［J］. Nucleic Acids Res, 2016, 44(7): e65. DOI: 10.1093/nar/gkv1491. ［13］ Wei X, Yu L, Li Y. PBX1 promotes the cell proliferation via JAK2/STAT3 signaling in clear cell renal carcinoma［J］. Biochem Biophys Res Commun, 2018, 500(3): 650-657. DOI: 10.1016/j.bbrc.2018.04.127. ［14］ Sun L, Burnett J, Gasparyan M, et al. Novel cancer stem cell targets during epithelial to mesenchymal transition in PTENdeficient trastuzumabresistant breast cancer［J］. Oncotarget, 2016, 7(32): 5140851422. DOI: 10.18632/oncotarget.9839. ［15］ Peng C, Lou HL, Liu F, et al. Enhanced identification of potential pleiotropic genetic variants for bone mineral density and breast cancer［J］. Calcif Tissue Int, 2017, 101(5): 489-500. DOI: 10.1007/s00223-017-0308-x. ［16］ Sun L, Yuan H, Burnett J, et al. MEOX1 promotes tumor progression and predicts poor prognosis in human nonsmallcell lung cancer［J］. Int J Med Sci, 2019, 16(1): 68-74. DOI: 10.7150/ijms.27595. ［17］ Zhu ZY, Wang XL, Li DP. Silencing of MEOX1 gene inhibits proliferation and promotes apoptosis of LNCaP cells in prostate cancer［J］. Cancer Biother Radiopharm, 2019, 34(2): 91-102. DOI: 10.1089/cbr.2018.2545. ［18］ Linn SC, West RB, Pollack JR, et al. Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans［J］. Am J Pathol, 2003, 163(6): 2383-2395. DOI: 10.1016/S00029440(10)635936. ［19］ Rodrigo I, Bovolenta P, Mankoo BS, et al. Meox homeodomain proteins are required for Bapx1 expression in the sclerotome and activate its transcription by direct binding to its promoter［J］. Mol Cell Biol, 2004, 24(7): 2757-2766. ［20］ Lu D, Wang J, Li J, et al. Meox1 accelerates myocardial hypertrophic decompensation through Gata4［J］. Cardiovasc Res, 2018, 114(2): 300-311. DOI: 10.1093/cvr/cvx222. ［21］ Savage J, Voronova A, Mehta V, et al. Canonical Wnt signaling regulates Foxc1/2 expression in P19 cells［J］. Differentiation, 2010, 79(1): 31-40. DOI: 10.1016/j.diff.2009.08.008. ［22］ Stamataki D, Kastrinaki M, Mankoo BS, et al. Homeodomain proteins Mox1 and Mox2 associate with Pax1 and Pax3 transcription factors［J］. FEBS Lett, 2001, 499(3): 274-278. ［23］ Wissmüller S, Kosian T, Wolf M, et al. The highmobilitygroup domain of Sox proteins interacts with DNAbinding domains of many transcription factors［J］. Nucleic Acids Res, 2006, 34(6): 1735-1744. DOI: 10.1093/nar/gkl105.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297.